Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -38,044 | -24,974 |
| Depreciation Amortization | 906 | 482 |
| Accounts payable and accrued liabilities | 2,402 | 797 |
| Other Working Capital | 3,645 | 478 |
| Other Operating Activity | 3,042 | 4,393 |
| Operating Cash Flow | $-28,049 | $-18,824 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 10,667 | 5,685 |
| PPE Investments | -7,921 | -3,415 |
| Net Acquisitions | -4,722 | -4,722 |
| Investing Cash Flow | $-1,976 | $-2,452 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 9,734 | N/A |
| Other Financing Activity | -144 | -11 |
| Financing Cash Flow | $9,590 | $-11 |
| Beginning Cash Position | 44,064 | 44,064 |
| End Cash Position | 23,629 | 22,777 |
| Net Cash Flow | $-20,435 | $-21,287 |
| Free Cash Flow | ||
| Operating Cash Flow | -28,049 | -18,824 |
| Capital Expenditure | -7,921 | -3,415 |
| Free Cash Flow | -35,970 | -22,239 |